Inventor · disambiguated record
Louis Anthony Tartaglia
Also filed as: TARTAGLIA LOUIS A · TARTAGLIA LOUIS ANTHONY
32 granted patents·15 pending applications·451 citations·filing 1994–2024
97Inventor score
Files withMILLENNIUM PHARM INC23RHYTHM PHARMACEUTICALS INC4EDITAS MEDICINE INC3WHITEHEAD BIOMEDICAL INST3ENTRADA THERAPEUTICS INC2
Top patents by PatentIndex Score
47 records- 0194US11987821B2Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathyENTRADA THERAPEUTICS INC·Filed 2021·Granted May 21, 2024·2 cites·18 claims
- 0292US6977240B1Methods of using the OB receptor antibodies to treat bodyweight disordersMILLENIUM PHARMACEUTICALS INC·Filed 2001·Granted Dec 20, 2005·26 cites·6 claims
- 0390US6346374B1Nucleic acid molecules encoding GLUTX and uses thereofMILLENNIUM PHARM INC·Filed 2000·Granted Feb 12, 2002·23 cites·8 claims
- 0488US6395498B1Methods of identifying compounds that modulate body weight using the OB receptorMILLENNIUM PHARM INC·Filed 1997·Granted May 28, 2002·68 cites·20 claims
- 0586US10954268B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2019·Granted Mar 23, 2021·1 cites·18 claims
- 0686US5972621AMethods of identifying compounds that modulate body weight using the OB receptorMILLENNIUM PHARM INC·Filed 1996·Granted Oct 26, 1999·59 cites·16 claims
- 0786US5942398ANucleic acid molecules encoding glutx and uses thereofMILLENNIUM PHARM INC·Filed 1998·Granted Aug 24, 1999·46 cites·23 claims
- 0884US2024190914A1Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0982US10167312B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2017·Granted Jan 1, 2019·2 cites·14 claims
- 1082US2025115885A1Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathyENTRADA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1181US5853975AMethods for identifying compositions for the treatment of body weight disorders, including obesityMILLENNIUM PHARM INC·Filed 1997·Granted Dec 29, 1998·25 cites·7 claims
- 1280US7842709B2Method for treating inflammatory diseases of the digestive tractORE PHARMACEUTICALS INC·Filed 2007·Granted Nov 30, 2010·8 cites·19 claims
- 1380US6518402B1Antibodies to c5 polypeptidesMILLENNIUM PHARM INC·Filed 2000·Granted Feb 11, 2003·3 cites·9 claims
- 1480US2024067992A1Human hematopoietic stem cell having a modified bcl11a gene and methods of making the cellEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1577US6057109ACompositions for the treatment of body weight disorders including obesityMILLENNIUM PHARM INC·Filed 1998·Granted May 2, 2000·20 cites·4 claims
- 1676US11702448B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM PHARMACEUTICALS INC·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 1773US9845339B2Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriersRHYTHM METABOLIC INC·Filed 2012·Granted Dec 19, 2017·2 cites·10 claims
- 1871US5702902AMethods for the diagnosis of body weight disorders including obesityMILLENNIUM PHARM INC·Filed 1995·Granted Dec 30, 1997·36 cites·11 claims
- 1970US6121017ACompositions for the treatment of body weight disorders, including obesityMILLENNIUM PHARM INC·Filed 1997·Granted Sep 19, 2000·12 cites·14 claims
- 2068US5741666ACompositions and methods, for the treatment of body weight disorders, including obesityMILLENNIUM PHARM INC·Filed 1994·Granted Apr 21, 1998·24 cites·16 claims
- 2167US2021040506A1Crispr-related methods and compositionsEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 2263US6348321B1Methods of identifying agents inhibiting fatty acid transport proteinsWHITEHEAD BIOMEDICAL INST·Filed 1999·Granted Feb 19, 2002·14 cites·80 claims
- 2363US2016237455A1Crispr-related methods and compositionsEDITAS MEDICINE INC·Filed 2014·Application pending·0 cites
- 2460US5861485APolypeptides involved in body weight disorders, including obesityMILLENNIUM PHARM INC·Filed 1995·Granted Jan 19, 1999·9 cites·10 claims
- 2559US6288213B1Fatty acid transport proteinsWHITEHEAD INST FOR BIOCHEMICAL·Filed 1999·Granted Sep 11, 2001·13 cites·14 claims
- 2659US2002182676A1Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexiaMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2758US6933115B2Nucleic acid molecules encoding GLUTX and uses thereofMILLENNIUM PHARM INC·Filed 2001·Granted Aug 23, 2005·0 cites·3 claims
- 2858US2007077205A1Use of non-invasive imaging technologies to monitor in vivo gene-expressionTARTAGLIA LOUIS A·Filed 2006·Application pending·0 cites
- 2957US6380363B1Antibodies to the Ob receptorFiled 1998·Granted Apr 30, 2002·11 cites·11 claims
- 3056US7547515B2Methods for detection of the Ob receptor and the diagnosis of body weight disorders, including obesity and cachexiaMILLENNIUM PHARM INC·Filed 2005·Granted Jun 16, 2009·0 cites·17 claims
- 3156US6506877B1Ob receptorMILLENNIUM PHARM INC·Filed 1995·Granted Jan 14, 2003·16 cites·3 claims
- 3254US2003053951A1Use of non-invasive imaging technologies to monitor in vivo gene-expressionMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3354US2009186014A1Method for treatment of pancreatitisORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3450US2003232363A1Fatty acid transport proteinsFiled 2003·Application pending·0 cites
- 3549US6403552B1Ob receptor and methods for the diagnosis and treatment of body weight disordersMILLENIUM PHARMACEUTICALS INC·Filed 1998·Granted Jun 11, 2002·7 cites·41 claims
- 3647US6136547ANucleic acid molecules encoding glutx and uses thereofMILLENNIUM PHARM INC·Filed 1999·Granted Oct 24, 2000·3 cites·14 claims
- 3746US6300096B1Polynucleotides encoding fatty acid transport proteinsWHITEHEAD BIOMEDICAL INST·Filed 1999·Granted Oct 9, 2001·11 cites·66 claims
- 3846US2013195762A1Fat cells and methods of using thereofEMBER THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3943US2008234345A1Method for reducing or alleviating inflammation in the digestive tractGENE LOGIC INC·Filed 2007·Application pending·0 cites
- 4041US2012009183A1Method for treatment of pancreatitisTARTAGLIA LOUIS ANTHONY·Filed 2011·Application pending·0 cites
- 4141US2001024808A1Leptin induced genesMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 4241US2002119517A1Leptin induced genesMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 4340US6482927B1Chimeric proteins comprising the extracellular domain of murine Ob receptorMILLENNIUM PHARM INC·Filed 1996·Granted Nov 19, 2002·1 cites·24 claims
- 4438US6509189B1Nucleic acid molecules encoding the cytoplasmic domain of human Ob receptorMILLENNIUM PHARM INC·Filed 1995·Granted Jan 21, 2003·4 cites·7 claims
- 4538US6287782B1Methods of using the Ob receptor to identify therapeutic compoundsMILLENNIUM PHARM INC·Filed 1998·Granted Sep 11, 2001·4 cites·7 claims
- 4637US6548269B1Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexiaMILLENNIUM PHARM INC·Filed 1996·Granted Apr 15, 2003·1 cites·14 claims
- 4729US7033772B1Methods of identifying inhibitors of fatty acid transport proteins (FATP)WHITEHEAD BIOMEDICAL INST·Filed 1999·Granted Apr 25, 2006·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Louis Anthony Tartaglia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →